MLAB Relative Valuation
MLAB's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MLAB is overvalued; if below, it's undervalued.
Historical Valuation
Mesa Laboratories Inc (MLAB) is now in the Overvalued zone, suggesting that its current forward PE ratio of 58.53 is considered Overvalued compared with the five-year average of 32.32. The fair price of Mesa Laboratories Inc (MLAB) is between 27.10 to 62.26 according to relative valuation methord. Compared to the current price of 76.39 USD , Mesa Laboratories Inc is Overvalued By 22.69%.
Relative Value
Fair Zone
27.10-62.26
Current Price：76.39
22.69%
Overvalued
59.12
PE
1Y
3Y
5Y
Trailing
Forward
9.17
EV/EBITDA
Mesa Laboratories Inc. (MLAB) has a current EV/EBITDA of 9.17. The 5-year average EV/EBITDA is 19.60. The thresholds are as follows: Strongly Undervalued below 5.50, Undervalued between 5.50 and 12.55, Fairly Valued between 26.66 and 12.55, Overvalued between 26.66 and 33.71, and Strongly Overvalued above 33.71. The current Forward EV/EBITDA of 9.17 falls within the Undervalued range.
9.71
EV/EBIT
Mesa Laboratories Inc. (MLAB) has a current EV/EBIT of 9.71. The 5-year average EV/EBIT is 21.86. The thresholds are as follows: Strongly Undervalued below 0.09, Undervalued between 0.09 and 10.97, Fairly Valued between 32.75 and 10.97, Overvalued between 32.75 and 43.63, and Strongly Overvalued above 43.63. The current Forward EV/EBIT of 9.71 falls within the Undervalued range.
1.66
PS
Mesa Laboratories Inc. (MLAB) has a current PS of 1.66. The 5-year average PS is 4.38. The thresholds are as follows: Strongly Undervalued below -0.60, Undervalued between -0.60 and 1.89, Fairly Valued between 6.88 and 1.89, Overvalued between 6.88 and 9.37, and Strongly Overvalued above 9.37. The current Forward PS of 1.66 falls within the Undervalued range.
10.84
P/OCF
Mesa Laboratories Inc. (MLAB) has a current P/OCF of 10.84. The 5-year average P/OCF is 21.35. The thresholds are as follows: Strongly Undervalued below -2.03, Undervalued between -2.03 and 9.66, Fairly Valued between 33.03 and 9.66, Overvalued between 33.03 and 44.72, and Strongly Overvalued above 44.72. The current Forward P/OCF of 10.84 falls within the Historic Trend Line -Fairly Valued range.
12.72
P/FCF
Mesa Laboratories Inc. (MLAB) has a current P/FCF of 12.72. The 5-year average P/FCF is 24.29. The thresholds are as follows: Strongly Undervalued below -2.61, Undervalued between -2.61 and 10.84, Fairly Valued between 37.74 and 10.84, Overvalued between 37.74 and 51.18, and Strongly Overvalued above 51.18. The current Forward P/FCF of 12.72 falls within the Historic Trend Line -Fairly Valued range.
Mesa Laboratories Inc (MLAB) has a current Price-to-Book (P/B) ratio of 2.36. Compared to its 3-year average P/B ratio of 2.86 , the current P/B ratio is approximately -17.58% higher. Relative to its 5-year average P/B ratio of 3.02, the current P/B ratio is about -21.99% higher. Mesa Laboratories Inc (MLAB) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 6.14%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 4.74% , the current FCF yield is about -100.00% lower.
2.38
P/B
Median3y
2.86
Median5y
3.02
8.83
FCF Yield
Median3y
6.14
Median5y
4.74
Competitors Valuation Multiple
The average P/S ratio for MLAB's competitors is , providing a benchmark for relative valuation. Mesa Laboratories Inc Corp (MLAB) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 5.02%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of MLAB decreased by 41.50% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 57.83M to 60.74M.
The secondary factor is the P/E Change, contributed -15.32%to the performance.
Overall, the performance of MLAB in the past 1 year is driven by Revenue Growth. Which is more sustainable.
People Also Watch
FAQ
Is Mesa Laboratories Inc (MLAB) currently overvalued or undervalued?
What is Mesa Laboratories Inc (MLAB) fair value?
How does MLAB's valuation metrics compare to the industry average?
What is the current P/B ratio for Mesa Laboratories Inc (MLAB) as of Dec 05 2025?
What is the current FCF Yield for Mesa Laboratories Inc (MLAB) as of Dec 05 2025?
What is the current Forward P/E ratio for Mesa Laboratories Inc (MLAB) as of Dec 05 2025?